Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Regains Compliance with Nasdaq Listing Requirements

CAMPBELL, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company that develops and commercializes novel therapeutic products to address...
September 24, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS to Present at the Fourth Annual Robins Equity Research Round-Up

CAMPBELL, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc., (NASDAQ: VVUS), a biopharmaceutical company that develops and commercializes novel therapeutic products to address unmet medical...
September 21, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Supports the Cystic Fibrosis Community Through Sponsorship of and Participation in the Cystic Fibrosis Foundation’s CF Climb

-Fundraising event at AT&T Stadium on September 22 supports the Dallas-Fort Worth chapter of the Cystic Fibrosis Foundation- CAMPBELL, Calif., Sept. 21, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc....
September 10, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Announces 1-for-10 Reverse Stock Split

CAMPBELL, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that the Company’s stockholders approved a reverse stock...
August 27, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Reports Data Supporting the Cardiovascular Safety of Qsymia®

-Retrospective analysis presented at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management- CAMPBELL, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc....
August 22, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 5, 2018

CAMPBELL, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and commercialization of innovative...
August 07, 2018 16:05 ET | Source: VIVUS, Inc.

VIVUS Reports Second Quarter 2018 Financial Results

Company to host conference call today at 4:30pm ET CAMPBELL, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a specialty pharmaceutical company committed...
August 06, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Appoints Kenneth Suh as President

CAMPBELL, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced the appointment of Ken Suh to the position of President. ...
July 31, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 7, 2018

CAMPBELL, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the second quarter of...
July 10, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Announces Positive Results from a Phase 1 Clinical Trial of VI-0106

-Favorable pharmacokinetic results add to body of data supporting continued development in the treatment of pulmonary arterial hypertension- CAMPBELL, Calif., July 10, 2018 (GLOBE NEWSWIRE) --...